Abstract: A hybridoma cell line of secreting cyproheptadine monoclonal antibodies with a preservation number of CGMCC No. 14699 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with cyproheptadine complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to cyproheptadine (value of IC50 is 0.37 ng/ml), being suitable for detection of cyproheptadine in food.

Abstract: Disclosed are an advanced persistent threat (APT) detection method and system based on a continuous-time dynamic heterogeneous graph network (CDHGN). The method includes: selecting network interaction event data, extracting entities from the network interaction event data as source nodes and target nodes, extracting an interaction event occurring between a source node and a target node as an edge, and determining a type and an attribute of a node, a type and an attribute of the edge, and a moment at which an interaction event occurs, to obtain a continuous-time dynamic heterogeneous graph; converting each type of edge in the continuous-time dynamic heterogeneous graph into a vector by a CDHGN encoder, to obtain an embedding representation by a CDHGN decoder to obtain a detection result of whether each type of edge is an abnormal edge, to intercept an APT attack.

Abstract: An application of CRMP2 and/or anti-CRMP2 antibodies as markers of a nervous system autoimmune disease, and an application of a reagent for detecting anti-CRMP2 antibodies in preparing a reagent for the detection. diagnosis, treatment or prognosis evaluation of a nervous system autoimmune disease. CRMP2 is a new encephalitis/encephalomyelitis-related autoantibody targeted molecular marker, which can be used for clear diagnosis of the disease and provide the basis for an immunotherapy solution. In addition, the treatment effect can be monitored and the prognosis and recurrence can be determined by detecting a titer change in CRMP2 autoantibodies.

Abstract: Disclosed are a method and a device for conference reservation, wherein the method includes: the conference time information and the position selection range information are matched with pre-stored conference resource information; if the matching succeeds, the conference is successfully reserved; if the matching fails, the conference is not successfully reserved; wherein the conference resource information includes idle or occupied status information based on a time axis for all terminals and resource consumption status information based on the time axis for a Multipoint Control Unit (MCU). The method and device according to the present disclosure can improve apparently the success rate of conference reservation, and can improve the utilization of equipment resources, thereby leading to an improvement on productivity.

Abstract: The disclosure discloses a telepresence method, a telepresence terminal and a telepresence system.

Abstract: Disclosed are a method and a device for conference reservation, wherein the method includes: the conference time information and the position selection range information are matched with pre-stored conference resource information; if the matching succeeds, the conference is successfully reserved; if the matching fails, the conference is not successfully reserved; wherein the conference resource information includes idle or occupied status information based on a time axis for all terminals and resource consumption status information based on the time axis for a Multipoint Control Unit (MCU). The method and device according to the present disclosure can improve apparently the success rate of conference reservation, and can improve the utilization of equipment resources, thereby leading to an improvement on productivity.

Abstract: The disclosure discloses a telepresence method, a telepresence terminal and a telepresence system.

Abstract: Techniques for intersystem Single Sign-On use intersystem user ID mapping to map user IDs of multiple systems. In one implementation, a method obtains a user's ID information associated with a first system, and obtains the user's ID information associated with a second system from the user's ID information associated with the first system according to the intersystem user ID mapping table. The first system sends the user's ID information associated with the second system to the second system, which may allow the user to automatically log on upon successful user ID verification. The user ID information communicated between the systems may be encrypted and decrypted using digital signature techniques. Systems for accomplishing the method are also provided.

Abstract: Techniques for intersystem Single Sign-On use intersystem user ID mapping to map user IDs of multiple systems. In one implementation, a method obtains a user's ID information associated with a first system, and obtains the user's ID information associated with a second system from the user's ID information associated with the first system according to the intersystem user ID mapping table. The first system sends the user's ID information associated with the second system to the second system, which may allow the user to automatically log on upon successful user ID verification. The user ID information communicated between the systems may be encrypted and decrypted using digital signature techniques. Systems for accomplishing the method are also provided.

Abstract: Techniques for intersystem Single Sign-On use intersystem user ID mapping to map user IDs of multiple systems. In one implementation, a method obtains a user's ID information associated with a first system, and obtains the user's ID information associated with a second system from the user's ID information associated with the first system according to the intersystem user ID mapping table. The first system sends the user's ID information associated with the second system to the second system, which may allow the user to automatically log on upon successful user ID verification. The user ID information communicated between the systems may be encrypted and decrypted using digital signature techniques. Systems for accomplishing the method are also provided.

Abstract: Techniques for intersystem Single Sign-On use intersystem user ID mapping to map user IDs of multiple systems. In one implementation, a method obtains a user's ID information associated with a first system, and obtains the user's ID information associated with a second system from the user's ID information associated with the first system according to the intersystem user ID mapping table. The first system sends the user's ID information associated with the second system to the second system, which may allow the user to automatically log on upon successful user ID verification. The user ID information communicated between the systems may be encrypted and decrypted using digital signature techniques. Systems for accomplishing the method are also provided.